OGDHL encodes a rate-limiting Krebs cycle enzyme that is proposed to be associated with a highly variable manifestation of neurological and neurodevelopmental disorders including developmental delay/intellectual disability, movement disorders, seizures, dysmorphism, as well as hearing and vision impairment. The gene discussed is OGDHL; the disease is movement disorder.